Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

777
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
777
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.4K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

720
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
720
Administering Oxygen by Nasal Cannula01:29

Administering Oxygen by Nasal Cannula

4.5K
Oxygen therapy is critical to patient care, especially for those struggling with respiratory issues. This intervention increases the oxygen concentration in the lungs, enhancing the amount of oxygen transported to the body's tissues. One standard method of delivering supplemental oxygen is through a nasal cannula, a non-invasive device that provides low to medium oxygen concentrations.
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
4.5K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

619
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
619

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of PERK signaling attenuates apoptosis in rat alveolar type II cells subjected to non-physiological mechanical strain.

Tissue & cell·2026
Same author

Sharing a whole-/total-body [<sup>18</sup>F]FDG-PET/CT dataset with CT-derived segmentations: an ENHANCE.PET initiative.

Scientific data·2026
Same author

Sex Differences in IPF: Data from the German INSIGHTS Registry.

Respiration; international review of thoracic diseases·2026
Same author

Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19.

Clinical therapeutics·2026
Same author

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Respiration; international review of thoracic diseases·2026
Same author

Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis.

ERJ open research·2026

Related Experiment Video

Updated: Mar 19, 2026

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
07:15

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Published on: December 5, 2025

558

Nasal highflow improves ventilation in patients with COPD.

Jens Bräunlich1, Marcus Köhler1, Hubert Wirtz1

  • 1Department of Respiratory Medicine, University of Leipzig, Leipzig, Germany.

International Journal of Chronic Obstructive Pulmonary Disease
|June 17, 2016
PubMed
Summary

Nasal highflow (NHF) therapy effectively reduces hypercapnia in COPD patients by improving breathing efficiency. This study shows NHF lowers partial pressure of CO2 (pCO2) and reduces the work of breathing.

Keywords:
NHFhypercapnianasal high flow cannulapCO2ventilation

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.7K
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.9K

Related Experiment Videos

Last Updated: Mar 19, 2026

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
07:15

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Published on: December 5, 2025

558
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.7K
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.9K

Area of Science:

  • Respiratory Medicine
  • Pulmonology
  • Critical Care Medicine

Background:

  • Nasal highflow (NHF) delivers warmed, humidified air, showing promise in acute hypoxemic respiratory failure.
  • Preliminary data suggest NHF may decrease hypercapnia in Chronic Obstructive Pulmonary Disease (COPD) patients.
  • NHF warrants evaluation as a novel ventilatory support for COPD.

Purpose of the Study:

  • To assess the impact of varying NHF flow rates on ventilatory parameters in severe COPD patients.
  • To characterize flow-dependent changes in airway pressure, breathing volumes, and pCO2.
  • To evaluate patient comfort and dyspnea during NHF use.

Main Methods:

  • Interventional study on severe COPD patients.
  • Measured mean airway pressure, breathing volumes, and breathing frequency at NHF flows of 20-50 L/min.
  • Assessed changes in capillary blood gas (pCO2) and patient-reported outcomes (dyspnea, comfort).

Main Results:

  • NHF demonstrated a minor, flow-dependent increase in mean airway pressure.
  • Tidal volume increased, breathing rate decreased, and the rapid shallow breathing index reduced.
  • Hypercapnia (pCO2) decreased with increasing NHF flow, alongside improved dyspnea.

Conclusions:

  • NHF therapy leads to a flow-dependent reduction in pCO2 in COPD patients.
  • This effect is likely due to respiratory tract washout and reduced dead space.
  • NHF enhances breathing effectiveness, reduces pCO2, and lowers the work of breathing in COPD.